1-[3-(5-bromo-1,3,4-thiadiazol-2-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2-hydroxy-2-methylpropan-1-one
C11H15BrN4O2S — CID 146382449
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-(5-bromo-1,3,4-thiadiazol-2-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2-hydroxy-2-methylpropan-1-one
1-[3-(5-bromo-1,3,4-thiadiazol-2-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2-hydroxy-2-methylpropan-1-one (PubChem CID 146382449) has the molecular formula C11H15BrN4O2S and a molecular weight of 347.24 g/mol. Its IUPAC name is 1-[3-(5-bromo-1,3,4-thiadiazol-2-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2-hydroxy-2-methylpropan-1-one.
Molecular Properties
| Compound Name | 1-[3-(5-bromo-1,3,4-thiadiazol-2-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2-hydroxy-2-methylpropan-1-one |
|---|---|
| PubChem CID | 146382449 |
| Molecular Formula | C11H15BrN4O2S |
| Molecular Weight | 347.24 g/mol |
| Exact Mass | 346.01 |
| IUPAC Name | 1-[3-(5-bromo-1,3,4-thiadiazol-2-yl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]-2-hydroxy-2-methylpropan-1-one |
| SMILES | CC(C)(O)C(=O)N1C2CC1CN(c1nnc(Br)s1)C2 |
| InChI | InChI=1S/C11H15BrN4O2S/c1-11(2,18)8(17)16-6-3-7(16)5-15(4-6)10-14-13-9(12)19-10/h6-7,18H,3-5H2,1-2H3 |
| InChIKey | CWPDPVZMNPLRLE-UHFFFAOYSA-N |
| XLogP | 0.86 |
| TPSA | 69.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 347.24 |
| LogP ≤ 5 | 0.86 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146382449 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.